CDNA CareDx, Inc.

NEUTRAL Impact: 2/10 DEFA14A
Horizon days Filed Jun 5, 2026 Processed 7d 17h ago SEC 0001104659-26-070996
Proxy solicitation materials

Price Chart

Loading chart...

Executive Summary

CareDx filed a DEFA14A supplementing its 2026 proxy statement to clarify the calculation of the 2025 cash bonus program metrics. The supplement provides as-adjusted figures for Adjusted EBITDA ($38.5M, 123% of target) and Cash ($288M, 200% of target), but does not change any previously disclosed bonus payouts or voting matters. This is a routine clarification with no material financial impact.

Actionable Insight

Routine proxy supplement with no new financial information. Monitor the June 11 annual meeting for say-on-pay vote outcome, but no immediate trading catalyst.

Key Facts

  • Supplement clarifies 2025 cash bonus program metrics: Revenue $380M (88% of target), Adjusted EBITDA $38.5M (123% of target), Cash $288M (200% of target).
  • Total financial goals achieved at 124% of target.
  • No changes to previously disclosed bonus payouts or voting proposals.
  • Annual meeting scheduled for June 11, 2026.

Financial Impact

No change to previously disclosed bonus amounts; total achievement 124% of target.

revenueadjusted EBITDAcash

Risk Factors

  • None from this filing; routine disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
62% bullish (13 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-070996
Document: 0001104659-26-070996-index-headers.html0001104659-26-070996
Document: 0001104659-26-070996-index.html0001104659-26-070996
Document: 0001104659-26-070996.txt0001104659-26-070996
5 reports for CDNA
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +14.57%Feb 24, 2026
Filters
Rows
Reports for CDNA — sortable, filterable
Type Now
Jun 5, 2026
7d ago
DEFA14A
NEUTRAL ★ 2/10
$23.16 awaiting T+20awaiting T+20$22.97 (−0.82%)
Apr 28, 2026
6w ago
S-3ASR
NEUTRAL ★ 5/10
$20.80 $22.16▲ +6.54%▲ +1.08%$22.97 (+10.43%)
Apr 16, 2026
8w ago
8-K
BULLISH ★ 8/10
$22.42 $20.61▼ −8.07%▼ −13.89%$22.97 (+2.45%)
Feb 25, 2026
15w ago
8-K/A
BULLISH ★ 8/10
$18.46 $18.08▼ −2.06%▲ +3.18%$22.97 (+24.43%)
Feb 24, 2026
15w ago
8-K
BULLISH ★ 7/10
$18.46 $18.08▼ −2.06%▲ +3.18%$22.97 (+24.43%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (47h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access